Logo
A

Ailomics Therapeutics

5 employees

Ailomics Therapeutics focuses on developing innovative drugs to treat immune diseases and tumors.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
deep learning
Therapeutics
omics data analysis
immunology
AI
computational biology

Date founded

2022

Funding rounds raised

A

Ailomics Therapeutics raised undisclosed on May 31, 2023

Investors: Qiming Venture Partners

A

Ailomics Therapeutics raised undisclosed on August 9, 2022

Investors: Qiming Venture Partners

FAQ